Refine by region/country
Latest articles in Health Care

Chularat Hospital PCL: Profit forecast upgrade prompts call upgrade

Earnings forecasts upgraded. New growth opportunity with asset-lite business model. Two new hospitals set to mark black ink for this year.
Bualuang Securities Narumon
Narumon Ekasamut @ Bualuang Securities 9 June 2021

Cleopatra Hospitals Group: A strong kick-off for 2021

CLHO reported solid 1Q21 revenues of EGP633 million, compared to EGP503 million in 1Q20, and compared to EGP611 million in 4Q20; showing an increase of 25.9% YoY and 3.7% QoQ. Solid annual performance came despite a strong comparable quarter that inc...
Pharos Holding Mariam
Mariam Wael @ Pharos Holding 7 June 2021

Integrated Diagnostics Holdings: A strong start supported by revenues from Covid tests and margin expansion

IDHC reported 1Q21 revenues of EGP1,130 million, up 126% YoY and up 14.6% QoQ. Net profit came in at EGP339 million for the quarter, a surge of 232% YoY and a rise of 44.6% QoQ, translating to a NPM of 30.0% (+9.6pps YoY, +6.2pps QoQ). IDHC operated ...
Pharos Holding Merna
Merna Arafat @ Pharos Holding 2 June 2021

TAAT Global Alternatives Inc. (CSE: TAAT / OTCQX: TOBAF / FRA: 2TP) Nicotine Free Smoking Experience / Sponsorship with Mayweather’s Team - Initiating Coverage

TAAT Global Alternatives Inc. (CSE: TAAT / OTCQX: TOBAF / FRA: 2TP) Nicotine Free Smoking Experience / Sponsorship with Mayweather’s Team - Initiating Coverage.Visit our website: https://www.researchfrc.com/  
Fundamental Research Corp Siddharth
Siddharth Rajeev @ Fundamental Research Corp 1 June 2021

Morning Bulletin - 28 May 2021

SOFIX 531.57 (-0.06%) inched lower on Thursday as some of the heaviest names weighed on the main index. Eurohold (EUBG, BGN 2.52, -1.56%), Telelink (TBS, BGN 14.70, -2.00%) and Chimimport (CHIM, BGN 0.888, -0.22%) lost altitude without significant d....
First Financial Brokerage House Veselin
Veselin Radoychev @ First Financial Brokerage House 28 May 2021

Genetron Health's self-developed mutation capsule differentiates it from others

Since the outbreak of COVID-19, new public health systems and advanced biotechnology have been swiftly hyped up. To be more precise, it generated 72.01% of the total revenue from laboratory-developed test (LDT), appearing as the most prominent busine...
EqualOcean Yangni
Yangni Liu @ EqualOcean 27 May 2021